References
- Xu YM, Gong ZJ, Wu HJ. Papillary thyroid carcinoma incidentally found in cervical lymph nodes during neck dissection for patients with tongue squamous cell carcinoma: a 3-case report and literature review. J Oral Maxillofac Surg. 2018;76(11):2454.e1–2454.e6.
- Liang Y, Lu B, Zhou C. Cervical adenoid basal carcinoma: clinicopathologic features of 9 cases with reference to CK17 and Ki-67 expression. J Low Genit Tract Dis. 2019;23(1):77–81.
- Dekker SE, Ostergard TA, Glenn CA, et al. Posterior cervical laminoplasty for resection intradural extramedullary spinal meningioma: 2-dimensional operative video. Oper Neurosurg. 2019;16(3):392.
- Palhares DMF, Marconi DG, Azevedo TL, et al. Predicting the necessity of adding catheters to intracavitary brachytherapy for women undergoing definitive chemoradiation for locally advanced cervical cancer. Brachytherapy. 2018;17(6):935–943.
- Shin JY, Choi KS, Suh M, et al. Comparison of cervical cancer screening among women with and without hysterectomies: a nationwide population-based study in Korea. BMC Cancer. 2018;18(1):810.
- Thapa N, Maharjan M, Xiong Y, et al. Impact of cervical cancer on quality of life of women in Hubei, China. Sci Rep.. 2018;8(1):11993.
- Su K, Zhao Q, Bian A, et al. A novel positive feedback regulation between long noncoding RNA UICC and IL-6/STAT3 signaling promotes cervical cancer progression. Am J Cancer Res. 2018;8(7):1176–1189.
- Chen G, Huang AC, Zhang W, et al. Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature. 2018;560(7718):382–386.
- Lam TS, van de Meent M, Marijt EWA, et al. Immune surveillance by autoreactive CD4-positive helper T cells is a common phenomenon in patients with acute myeloid leukemia. Eur J Haematol. 2018;101(5):665.
- Fridman WH. From cancer immune surveillance to cancer immunoediting: birth of modern immuno-oncology. J Immunol. 2018;201(3):825–826.
- Liu W, Wei X, Li L, et al. CCR4 mediated chemotaxis of regulatory T cells suppress the activation of T cells and NK cells via TGF-beta pathway in human non-small cell lung cancer. Biochem Biophys Res Commun. 2017;488(1):196–203.
- Shabaneh TB, Molodtsov AK, Steinberg SM, et al. Oncogenic BRAF(V600E) governs regulatory T-cell recruitment during melanoma tumorigenesis. Cancer Res. 2018;78(17):5038–5049.
- Chen X, Takemoto Y, Deng H, et al. Histidine decarboxylase (HDC)-expressing granulocytic myeloid cells induce and recruit Foxp3(+) regulatory T cells in murine colon cancer. Oncoimmunology. 2017;6(3):e1290034.
- Lu Y, Li S, Ma L, et al. Type conversion of secretomes in a 3D TAM2 and HCC cell co-culture system and functional importance of CXCL2 in HCC. Sci Rep. 2016;6(1):24558.
- Lezmi G, Leite-de-Moraes M. Invariant natural killer T and mucosal-associated invariant T cells in asthmatic patients. Front Immunol. 2018;9:1766.
- Smyk DS, Mavropoulos A, Mieli-Vergani G, et al. The role of invariant NKT in autoimmune liver disease: can vitamin D act as an immunomodulator? Can J Gastroenterol Hepatol. 2018;2018:8197937.
- Zhu L, Xie X, Zhang L, et al. TBK-binding protein 1 regulates IL-15-induced autophagy and NKT cell survival. Nat Commun. 2018;9(1):2812.
- Wang XZ, Xue RF, Zhang SY, et al. Activation of natural killer T cells contributes to triptolide-induced liver injury in mice. Acta Pharmacol Sin. 2018;39(12):1847–1854.
- Bae EA, Seo H, Kim BS, et al. Activation of NKT cells in an anti-PD-1-resistant tumor model enhances antitumor immunity by reinvigorating exhausted CD8 T cells. Cancer Res. 2018;78(18):5315–5326.
- Zhao M, Svensson MND, Venken K, et al. Altered thymic differentiation and modulation of arthritis by invariant NKT cells expressing mutant ZAP70. Nat Commun. 2018;9(1):2627.
- Wang HX, Li WJ, Hou CL, et al. CD1d-dependent natural killer T cells attenuate angiotensin II-induced cardiac remodeling via IL-10 signaling in mice. Cardiovasc Res. 2018.
- Fujii SI, Yamasaki S, Sato Y, et al. Vaccine designs utilizing invariant NKT-licensed antigen-presenting cells provide NKT or T cell help for B cell responses. Front Immunol. 2018;9:1267.
- Hoshino A, Tanita K, Kanda K, et al. High frequencies of asymptomatic Epstein-Barr virus viremia in affected and unaffected individuals with CTLA4 mutations. Clin Immunol. 2018;195:45–48.
- Guo H, Xu B, Gao L, et al. High frequency of activated natural killer and natural killer T-cells in patients with new onset of type 2 diabetes mellitus. Exp Biol Med. 2012;237(5):556–562.
- van Gysen K, Stevens M, Guo L, et al. Validation of the 8th edition UICC/AJCC TNM staging system for HPV associated oropharyngeal cancer patients managed with contemporary chemo-radiotherapy. BMC Cancer. 2019;19(1):674.
- Joo JH, Kim YS, Nam JH. Prognostic significance of lymph node ratio in node-positive cervical cancer patients. Medicine. 2018;97(30):e11711.
- Lopes J, Horta M, Cunha TM. Endometrial cancer after radiation therapy for cervical carcinoma: a radiological approach. Eur J Radiol. 2018;105:283–288.
- Dorta-Estremera S, Colbert LE, Nookala SS, et al. Kinetics of intratumoral immune cell activation during chemoradiation for cervical cancer. Int J Radiat Oncol Biol Phys. 2018;102(3):593–600.
- Kawachi A, Yoshida H, Kitano S, et al. Tumor-associated CD204(+) M2 macrophages are unfavorable prognostic indicators in uterine cervical adenocarcinoma. Cancer Sci. 2018;109(3):863–870.
- Tang X, Tan L, Shi K, et al. Gold nanorods together with HSP inhibitor-VER-155008 micelles for colon cancer mild-temperature photothermal therapy. Acta Pharm Sin B. 2018;8(4):587–601.
- Narvaez J, Juarez-Lopez P, J LL, et al. Rheumatic immune-related adverse events in patients on anti-PD-1 inhibitors: fasciitis with myositis syndrome as a new complication of immunotherapy. Autoimmun Rev. 2018;17(10):1040–1045.
- Tang X, Yang L, Li Z, et al. First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia. Am J Cancer Res. 2018;8(6):1083–1089.
- Lin J, Long J, Wan X, et al. Classification of gallbladder cancer by assessment of CD8(+) TIL and PD-L1 expression. BMC Cancer. 2018;18(1):766.
- Lee M, Tayyari F, Pinnaduwage D, et al. Tumoral BRD4 expression in lymph node-negative breast cancer: association with T-bet + tumor-infiltrating lymphocytes and disease-free survival. BMC Cancer. 2018;18(1):750.
- Vuletic A, Jovanic I, Jurisic V, et al. IL-2 And IL-15 induced NKG2D, CD158a and CD158b expression on T, NKT- like and NK cell lymphocyte subsets from regional lymph nodes of melanoma patients. Pathol Oncol Res. 2018.
- Tang B, Wu W, Wei X, et al. Activation of glioma cells generates immune tolerant NKT cells. J Biol Chem. 2014;289(50):34595–34600.
- Simon B, Wiesinger M, Marz J, et al. The generation of CAR-transfected natural killer T cells for the immunotherapy of melanoma. Int J Mol Sci. 2018;19(8):2365.
- Hoya M, Nagamatsu T, Fujii T, et al. Impact of Th1/Th2 cytokine polarity induced by invariant NKT cells on the incidence of pregnancy loss in mice. Am J Reprod Immunol. 2018;79(3):e12813.
- Nwani NG, Sima LE, Nieves-Neira W, et al. Targeting the microenvironment in high grade serous ovarian cancer. Cancers. 2018;10(8):266.
- Saleem J, Wang L, Chen C. Carbon-based nanomaterials for cancer therapy via targeting tumor microenvironment. Adv Healthcare Mater. 2018;7(20):1800525.
- Sun L, Xie S, Ji X, et al. MMP-2-responsive fluorescent nanoprobes for enhanced selectivity of tumor cell uptake and imaging. Biomater Sci. 2018;6(10):2619–2626.
- Adeegbe DO, Liu S, Hattersley MM, et al. BET bromodomain inhibition cooperates with PD-1 blockade to facilitate antitumor response in Kras-mutant non-small cell lung cancer. Cancer Immunol Res. 2018;6(10):1234–1245.
- Pan Z, Di S, Shi B, et al. Increased antitumor activities of glypican-3-specific chimeric antigen receptor-modified T cells by coexpression of a soluble PD1-CH3 fusion protein. Cancer Immunol Immunother. 2018;67(10):1621–1634.
- Cheng Y, Li H, Deng Y, et al. Cancer-associated fibroblasts induce PDL1+ neutrophils through the IL6-STAT3 pathway that foster immune suppression in hepatocellular carcinoma. Cell Death Dis. 2018;9(4):422.
- Nunez SY, Ziblat A, Secchiari F, et al. Human M2 macrophages limit NK cell effector functions through secretion of TGF-beta and engagement of CD85j. J Immunol. 2018;200(3):1008–1015.